Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension I: Introduction01:28

Hypertension I: Introduction

1.1K
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.1K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

686
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
686
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

792
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
792
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

554
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
554
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

4.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.6K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.2K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic Performance of Routine Abdominal MRI for Detecting Left Ventricular Hypertrophy in ADPKD.

Journal of computer assisted tomography·2026
Same author

Cardio-Thoracic Ratio for Detecting Left Ventricular Hypertrophy on Abdominal MRI in ADPKD.

Journal of magnetic resonance imaging : JMRI·2026
Same author

Author's Reply: Unrecognized Biases and Validation Gaps in TraceOrg for Automated Autosomal Dominant Polycystic Kidney Disease Volumetry.

Journal of the American Society of Nephrology : JASN·2026
Same author

Natural history of simple and complex cysts in autosomal dominant polycystic kidney disease on MRI.

Communications medicine·2026
Same author

Automatically Measuring Kidney, Liver, and Cyst Volumes in Autosomal Dominant Polycystic Kidney Disease.

Journal of the American Society of Nephrology : JASN·2025
Same author

Deep learning-based liver cyst segmentation in MRI for autosomal dominant polycystic kidney disease.

Radiology advances·2025

Related Experiment Video

Updated: Mar 2, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.3K

Unsuccessfully Treated Hypertension: A Major Public Health Problem With a Potential Solution.

Curt D Furberg1, Jean E Sealey2, Jon D Blumenfeld2,3

  • 1Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

American Journal of Hypertension
|May 9, 2017
PubMed
Summary
This summary is machine-generated.

Plasma renin guided therapy can improve blood pressure control in hypertensive adults. Tailoring antihypertensive drugs based on plasma renin levels, specifically using renin-angiotensin system (RAS) blockers for high renin and natriuretic agents for low renin, is key.

Keywords:
anti-renin treatmentanti-volume treatmentblood pressurehigh blood pressurehypertension, plasma renin activity, PRA

More Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.3K
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

803

Related Experiment Videos

Last Updated: Mar 2, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.3K
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.3K
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

803

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Public Health

Background:

  • Hypertension affects many adults, with about half experiencing uncontrolled blood pressure despite guideline-adherent medications.
  • Current treatment guidelines do not fully recognize the clinical relevance of the circulating renin-angiotensin system (RAS) in hypertension management.
  • Body salt status is considered important, but the role of RAS in blood pressure regulation is often overlooked.

Purpose of the Study:

  • To highlight the public health problem of uncontrolled hypertension.
  • To advocate for the integration of plasma renin levels into hypertension treatment strategies.
  • To propose specific improvements in drug labeling and clinical guidelines.

Main Methods:

  • A comprehensive literature review was conducted.
  • Analysis of existing hypertension treatment guidelines and drug indications.
  • Evaluation of the role of the renin-angiotensin system (RAS) in blood pressure regulation.

Main Results:

  • The circulating renin-angiotensin system (RAS) is not adequately recognized in current hypertension treatment guidelines.
  • Antihypertensive drug package inserts lack specificity regarding optimal patient selection based on renin levels.
  • Renin-angiotensin system (RAS) blockers are most effective in patients with medium to high plasma renin levels.
  • Natriuretic drugs demonstrate greater efficacy in patients with low plasma renin levels.

Conclusions:

  • Package inserts for antihypertensive drugs should specify indications based on plasma renin levels.
  • Clinical practice guidelines should incorporate plasma renin levels for targeted therapy.
  • Renin-angiotensin system (RAS) blockers are indicated for hypertension with medium/high renin levels; natriuretic agents for low renin levels.
  • Addressing prescription fulfillment and patient adherence are also crucial for blood pressure control.